Objective: To evaluate the treatment efficacy of type 1 diabetes mellitus during 18 months with a continuous subcutaneous insulin infusion pump and insulin lispro. The following paramethers were studied: glycosylated hemoglobin, weight, body mass index, amount of insulin administered daily, ratio between daily insulin dose and weight, ratio between insulin administered as bolus and as basal and the colateral effects of this form of therapy. After 18 months the patients were in better diabetic control with a significant lower level of glycosylated hemoglobin (p< 0.05). They presented a significant reduction in the ratio between insulin daily dose and weight (p< 0.05) and a better utilization of insulin related to meal observed by the significant rise in the ratio between insulin administered as bolus and as basal when compared with the ratio of regular and NPH before the SCII treatment (p< 0.05).
Type 1 diabetes mellitus; Continuous subcutaneous insulin infusion; Insulin lispro
